About this trial
The purpose of this research is to compare the standard ambulatory ECG monitor, the MoMe ARC, against Fourth Frontier's "Frontier X Plus". This device is an FDA-Cleared chest-strap-based ECG wearable that provides an alternative modality to capture ambulatory ECG rhythm changes.
Eligibility criteria
Qualifiers
Adult participants (>22 years; Frontier X is approved for use in this age group) who participate in >4 days a week of >150 minutes total per week of moderate to high intensity exercise who were prescribed a ambulatory ECG monitor for clinical purposes for 24 hours or more.
Patients must agree to wear the Frontier X monitor for the prescribed duration and use the Frontier X Plus application
Disqualifiers
Current use of Implanted Cardiac Devices
Pregnancy
Known allergies to any of the materials listed in the "List of Patient-Contacting Materials"
Presence of skin injuries or broken skin in the area where the chest strap is worn
Trial design
Treatments tested in this trial
- Frontier X Plus chest-strap ECG device
- MoMe ARC ambulatory ECG monitor